Additionally, a comprehensive review of the literature prior to 2009 suggested that anti-TNFα treatments in psoriasis might carry an elevated risk of cancer, particularly non-melanoma skin cancers and hematologic malignancies [55]. The gene discussed is TNF; the disease is hematologic disorder.